Irshad A Hajam

[Irshad A Hajam @aalirshad]

@Thomas_james_1 Rightly said, James

[Irshad A Hajam @aalirshad]

@DaveHcontrarian Thank you so much, David. I completely agree with you. Charts are saying it all.

[Globe Observer @_GlobeObserver]

🚨 BREAKING:

"Israel wanted to assassinate Iran's Foreign Minister Aragchi and speaker Ghalibaf. It had coordinates of their movements. Pakistan intelligence got the information about Israeli plans.

Pakistan informed US that if Israel kills Abbas Aragchi and Ghalibaf, there will be no one left in Iran to talk to. Iran will be taken over by the hardcore IRGC commanders.

At this, US intervened and stopped Israel from carrying out strikes to eliminate Aragchi and Ghalibaf. "

- Pakistani official to Reuters

[Irshad A Hajam @aalirshad]

@Arhdan9 @BlackRock @Vanguard_Group 100 dollar is coming. First 50 then pull back then to 88. Not a financial advice. Purely technical based analysis

[Irshad A Hajam @aalirshad]

@GrantCardone First, it may fall to around $74K, then rise to $90–102K, and afterward drop back to the $35–50K range. That’s what my charts suggest for now, though I could be wrong — let’s see how it plays out.

[Irshad A Hajam @aalirshad]

@__MrZzz__ @nezancho @RobinhoodApp Very good reply. I love it.

[Irshad A Hajam @aalirshad]

@Arhdan9 I like your conviction about this company. From the charts, it looks like the stock may pull back toward the 22–14 range, though I could be wrong. That said, I believe it has the potential to reach 100 within the next couple of months.

[Irshad A Hajam @aalirshad]

@Mustafa4263081 I think it could drop to around 16, but I could be wrong.

[Irshad A Hajam @aalirshad]

@Arhdan9 In my opinion, the stock could climb to around $50, then potentially pull back to somewhere between $25–$14, and later move above $100. This is just my personal analysis based on the chart, and I could be completely wrong. This is not financial advice.

[Irshad A Hajam @aalirshad]

Comparative transcriptome analysis of acne vulgaris, rosacea, and hidradenitis suppurativa supports high‐dose dietary zinc as a therapeutic agent - Li - 2024 - Experimental Dermatology - Wiley Online Library https://t.co/x18EfpLScc

[Irshad A Hajam @aalirshad]

Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures https://t.co/97tGpZVPUv #mdpiantibiotics via @antibioticsmdpi

[Irshad A Hajam @aalirshad]

Exploring the potential of Salmonella-mediated anti-sense RCAS1 RNA therapy in combatting aggressive breast cancer: Molecular Therapy - Nucleic Acids https://t.co/rG7ouWCTuQ

[Irshad A Hajam @aalirshad]

https://t.co/Pd2T8WITX3

[Irshad A Hajam @aalirshad]

https://t.co/ydApGzdKSu

[Irshad A Hajam @aalirshad]

AddThis | Home https://t.co/ViKqmjBPAX

[Irshad A Hajam @aalirshad]

AddThis | Home https://t.co/OFWpSWnPKg

[Irshad A Hajam @aalirshad]

Bacterial ghosts as adjuvants: mechanisms and potential: https://t.co/ddKeqf56gL via @medworm_

[Irshad A Hajam @aalirshad]

@SehwagSchool 9